Loading...
  • market for dronabinol
  • Dronabinol has the potential to change the way in which sleep apnea is treated throughout the world and we're excited to work with Respire towards our mutual goal to open this new market for dronabinol," said Mr. Joel Latham, Chief Executive Officer of Impression. (globenewswire.com)
  • We believe that the potential OSA market is extremely large, many times larger than the current market for dronabinol for currently approved indications, so the commitment by Noramco to provide clinical material and to ensure commercial supply demonstrates our mutual belief that dronabinol for OSA can be a commercial success. (ellymackay.com)
  • SYNDROS
  • SYNDROS is the first and only FDA-approved liquid dronabinol. (globenewswire.com)
  • On July 1, 2016, the U.S. Food and Drug Administration (FDA) approved a new drug application for Syndros, a drug product consisting of dronabinol [(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)] oral solution. (usdoj.gov)
  • As such, the DEA notes that the FDA approved a New Drug Application (NDA) for Syndros which is an oral product containing dronabinol and provided the DEA with a scheduling recommendation for Syndros. (usdoj.gov)
  • As stated in the interim final rule, after careful consideration of data from preclinical and clinical studies, the DEA concurred with the HHS recommendation that Syndros has abuse potential comparable to other schedule II substances and therefore supported--and continues to support in this final rule--placement of FDA-approved products containing dronabinol in an oral solution in Schedule II under the Controlled Substances Act (CSA). (usdoj.gov)
  • Nausea and Vomiting
  • Dronabinol is also used to treat severe nausea and vomiting caused by cancer chemotherapy. (healthbanks.com)
  • Dronabinol is for use only when other medications have been unable to control the nausea and vomiting. (healthbanks.com)
  • To prevent nausea and vomiting , dronabinol is usually given 1 to 3 hours before your chemotherapy treatment, and then every 2 to 4 hours (up to 6 doses total). (healthbanks.com)
  • Dronabinol is also approved by the FDA for the prevention of nausea and vomiting caused by certain cancer treatments. (thebody.com)
  • DRONABINOL (droe NAB i nol) is used to treat nausea and vomiting caused by cancer treatment, especially for those patients who do not respond to other medicines. (ahealthyme.com)
  • There are currently insufficient data to support the beneficial effects of dronabinol in the prevention of breakthrough chemotherapy-induced nausea and vomiting (CINV) in patients unresponsive to antiemetics, according to a review published in the journal Cancer Management and Research . (oncologynurseadvisor.com)
  • The primary purpose of the study is to determine the efficacy of oral dronabinol versus standard ondansetron antiemetic therapy in preventing delayed-onset chemotherapy-induced nausea and vomiting (CINV) or retching by measuring the incidence of total response of nausea and vomiting and/or retching following administration of moderate-to-high emetogenic chemotherapeutic agents. (clinicaltrials.gov)
  • The goal of this clinical research study is to learn if adding dronabinol in combination with the standard of care (dexamethasone and palonosetron) can better help to control nausea and vomiting in patients receiving chemotherapy. (clinicaltrials.gov)
  • Dronabinol and palonosetron are both designed to help prevent nausea and vomiting in patients who are receiving chemotherapy. (clinicaltrials.gov)
  • Dronabinol is currently approved by the US Food and Drug Administration for the treatment of nausea and vomiting for patients undergoing chemotherapy. (mdmag.com)
  • drugs
  • Some side effects may not need medical attention since they go away on their own as the body adjusts to dronabinol, according to Drugs.com. (reference.com)
  • Doctors should know about other drugs a patient is taking, as medications such as dextroamphetamine, antihistamines, sedatives and sleeping pills interact with dronabinol. (reference.com)
  • synthetic
  • This is an investigator-initiated proof of concept study with the purpose to examine the safety, tolerability and feasibility of Dronabinol (synthetic Δ9-THC) and PEA for the treatment of adults with Tourette syndrome. (clinicaltrials.gov)
  • medication
  • Dronabinol may also be used for purposes not listed in this medication guide. (healthbanks.com)
  • CONCLUSIONS: Dronabinol appeared to be effective in improving pain affect and psychosocial functioning in the treatment of refractory neuropathic pain and may be considered as an adjuvant medication in the rehabilitation process. (hindawi.com)
  • How long does it take the side effects of Dronabinol to wear off once the medication is stopped? (healthtap.com)
  • Dronabinol is a medication, whereas the current therapies available involve either mechanical approaches to open the airway, or surgical approaches of the upper airway, including a nerve stimulation device,' Phyllis Zee, MD, PhD, the Benjamin and Virginia T. Boshes professor of neurology at Northwestern University Feinberg School of Medicine and director of the Northwestern Medicine Sleep Disorders Center, said. (mdmag.com)
  • significant unmet
  • It represents a viable alternative for the delivery of dronabinol and will fulfill a significant unmet need for both cancer patients undergoing chemotherapy who fail traditional antiemetics and AIDS patients who experience weight loss," said Stephen Sherman, Senior Vice President, Regulatory Affairs of INSYS. (globenewswire.com)
  • RespireRx
  • To date, RespireRx has focused on dronabinol development in the United States, where approximately 29.4 million individuals have OSA, according to the American Academy of Sleep Medicine. (globenewswire.com)
  • RespireRx Pharmaceuticals Inc has entered into a dronabinol development and supply agreement with Noramco Inc, a North American producer of controlled substances bulk active pharmaceutical ingredients (API). (ellymackay.com)
  • We look forward to partnering with RespireRx with high-quality dronabinol as the company moves toward regulatory approval. (ellymackay.com)
  • CPAP
  • Compared to even complete compliance with mechanical treatment with CPAP, the severity of OSA was reduced by 33% with dronabinol. (mdmag.com)
  • 2017
  • On March 23, 2017, the DEA published an interim final rule to make FDA-approved products containing dronabinol in an oral solution a schedule II controlled substance. (usdoj.gov)
  • capsule
  • Dronabinol comes in capsule form and is taken by mouth. (thebody.com)
  • There are significant FDA and DEA regulatory and manufacturing complexities surrounding the dronabinol supply chain, considered a DEA Schedule I drug as API and a Schedule III drug as a gel capsule. (ellymackay.com)
  • drug
  • Never share dronabinol with another person, especially someone with a history of drug abuse or addiction. (healthbanks.com)
  • The initial intent of the parties is to create an appropriate commercial vehicle in order to rapidly introduce dronabinol to the Australian market through the Special Access Scheme which permits, under certain circumstances, prescriptions of identified unregistered drug products. (globenewswire.com)
  • The Drug Enforcement Administration (DEA) maintains FDA-approved products of oral solutions containing dronabinol in schedule II of the Controlled Substances Act. (usdoj.gov)
  • commitment
  • Their ability to access the Australian OSA market through their existing distribution and sales network, along with their commitment to commercializing dronabinol, makes them an ideal partner to bring dronabinol to this market. (globenewswire.com)
  • depression
  • METHODS: We studied the response (reduction of pain intensity and functional improvement) to dronabinol (5 mg/day to 25 mg/day) in two adolescents with neuropathic pain and depression refractory to previous treatments over two and five years, respectively. (hindawi.com)